Status:
COMPLETED
Sugammadex and Smoker's Neuromuscular Block
Lead Sponsor:
Duzce University
Conditions:
Neuromuscular Blockade
Smoking
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
We compared the durations of antagonizing and of the severity of effect of sugammadex used in antagonizing the rocuronium in smoker and non-smoker total 40 patients with using Train of Four(TOF) neuro...
Detailed Description
40 patients from American Society of Anesthesiologist (ASA) I- II class, being smokers for at least 10 years or non-smokers, who will undergo elective surgery were included in this randomized prospect...
Eligibility Criteria
Inclusion
- Elective surgery,
- 1-2 according to the ASA ( American Society of Anesthesiologist ) physical status classification.
- Patients who have smoked at least 10 packs or have been smoking for 10 years and currently smoking
- Or never smoked patients
Exclusion
- neuromuscular diseases
- radiotherapy and/or chemotherapy anamnesis,
- liver and/or renal disease,
- electrolyte balance,
- history of drug use which affects neuromuscular transmission,
- Body Mass Index (BMI) of more than 27,
- use alcohol
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05313100
Start Date
April 1 2012
End Date
August 1 2013
Last Update
April 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.